Streetbeat News

Products Services

ANTX

AN2 Therapeutics, Inc. (Nasdaq: ANTX) reported its Q3 2024 financial results and provided an update on the EBO-301 trial, highlighting progress in its boron chemistry pipeline. The company focuses on developing novel small molecule therapeutics.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

ATRA

Atara Biotherapeutics will participate in the Stifel 2024 Healthcare Conference, with CEO Cokey Nguyen speaking in a fireside chat. The company is known for its T-cell immunotherapy platform targeting cancer and autoimmune diseases.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

KSCP

VZ

Verizon has partnered with Knightscope to enhance connectivity for Knightscope's advanced public safety technology. Knightscope's K5 GOV Autonomous Security Robot has received FedRAMP Approval to serve the U.S. Department of Veterans Affairs.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

ALMS

Alumis Inc. reported its Q3 2024 financial results, highlighting progress in its clinical programs, including Phase 3 trials for ESK-001 in plaque psoriasis and Phase 2b trials for systemic lupus erythematosus.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

SCPH

scPharmaceuticals Inc. reported a significant increase in Q3 2024 revenue, driven by FUROSCIX sales, and announced a label expansion and positive data on their Autoinjector program. The company completed a $125 million financing to support its path to profitability.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

GPCR

Structure Therapeutics has initiated dosing in its Phase 2b ACCESS clinical study for GSBR-1290, an oral GLP-1 receptor agonist aimed at treating obesity. The study will evaluate various doses over 36 weeks, with results expected in late 2025.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

AMZN

Amazon's Prime Video has partnered with Diamond Sports to stream 16 regional sports networks, now branded as FanDuel Sports Networks, as an add-on subscription for Prime customers in specific areas.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

AAAU

IG's Rudolph suggests that gold at around $2,600/oz presents a buying opportunity due to long-term support and constrained supply.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

FDMT

4D Molecular Therapeutics (Nasdaq: FDMT) reported its Q3 2024 financial results, operational highlights, and upcoming milestones. The company is focused on genetic medicines for large market diseases.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

ICAD

iCAD, Inc. reported its financial results for Q3 2024, highlighting its role as a leader in AI-powered breast health solutions.

Portfolio Pulse from

November 13, 2024 | 9:15 pm